Clinical Trials Logo

Malignant Neoplasm clinical trials

View clinical trials related to Malignant Neoplasm.

Filter by:

NCT ID: NCT02129049 Completed - Breast Cancer Clinical Trials

Telephone-Based Educational Intervention in Improving Communication Between Patients With Stage 0-III Cancer and Their Children

Start date: April 2014
Phase: N/A
Study type: Interventional

This pilot clinical trial studies the feasibility of a telephone-based educational intervention in improving communication between patients with stage 0-III cancer and their children. An educational program delivered by telephone may help parents talk with their school-age child about their cancer.

NCT ID: NCT02081794 Completed - Malignant Neoplasm Clinical Trials

Tailoring Patient Education to Perceived Risk for Falls in Hospitalized Oncology Patients

Start date: February 2014
Phase: N/A
Study type: Interventional

This randomized pilot clinical trial studies tailored patient educational intervention or standard education in assessing perceived risk for falls in hospitalized oncology patients. A tailored patient educational intervention may be more beneficial than standard education in preventing patients from falling by increasing the patient's knowledge of the risk factors for falling routinely and then providing education in deficit areas. Making patients more aware of the risk factors for falling may lead to greater engagement in preventative activities.

NCT ID: NCT02071537 Completed - Solid Tumors Clinical Trials

Chloroquine in Combination With Carboplatin/Gemcitabine in Advanced Solid Tumors

Start date: May 13, 2014
Phase: Phase 1
Study type: Interventional

The purpose of this research study is to test the safety of chloroquine in combination with carboplatin and gemcitabine and see what effects (good and bad) it has on advanced solid tumors. Also, the research study will be increasing the dose of chloroquine to find the highest dose of chloroquine that can be given in combination with carboplatin and gemcitabine without causing severe side effects.

NCT ID: NCT02054715 Completed - Malignant Neoplasm Clinical Trials

Multimedia Psychoeducation or Print Education in Preparing Cancer Patients for Decision Making About Clinical Trials

Start date: May 1, 2014
Phase: N/A
Study type: Interventional

This randomized clinical trial compares multimedia psychoeducation to print education in preparing patients with cancer for decision making about clinical trial participation. Multimedia psychoeducation includes a digital video disc (DVD) and written materials with a combined focus on knowledge and attitude change, and may be an effective method to help patients prepare for decision making about clinical trial participation. It is not yet known whether a multimedia psychoeducation is more effective than print education in preparing patients for decision making about clinical trials.

NCT ID: NCT01982123 Completed - Malignant Neoplasm Clinical Trials

SPECT/CT in Measuring Lung Function in Patients With Cancer Undergoing Radiation Therapy

Start date: January 17, 2014
Phase: N/A
Study type: Interventional

This pilot clinical trial studies single photon emission computed tomography (SPECT)/computed tomography (CT) in measuring lung function in patients with cancer undergoing radiation therapy. Diagnostic procedures that measure lung function may help doctors find healthy lung tissue and allow them to plan better treatment.

NCT ID: NCT01970254 Completed - Cancer Clinical Trials

Widespread vs. Selective Screening for Hepatitis B Infection Prior to Chemotherapy

Start date: June 24, 2013
Phase:
Study type: Observational

This trial studies hepatitis B screening strategies of new cancer patients scheduled to undergo chemotherapy. Patients with cancer and hepatitis B virus infection are at risk of reactivation of infection after chemotherapy. Hepatitis B virus infection reactivation can be prevented by starting antivirals before chemotherapy in patients who are hepatitis B virus infection positive. Hepatitis B screening may help doctors prevent the reactivation of hepatitis B virus infection after chemotherapy.

NCT ID: NCT01946217 Completed - HIV Infection Clinical Trials

Factors Affecting Patient Participation in AIDS Malignancy Clinical Trials Consortium Clinical Trials

Start date: September 2013
Phase: N/A
Study type: Observational

This pilot research trial studies factors affecting patient participation in Acquired Immune Deficiency Syndrome (AIDS) Malignancy Clinical Trials Consortium clinical trials. Determining how patients makes decisions about participating in a clinical trial may help doctors plan clinical trials in which more patients are willing to participate and are satisfied with their decision to participate.

NCT ID: NCT01941810 Completed - Malignant Neoplasm Clinical Trials

Bovine Lactoferrin Supplement in Improving Taste in Patients With Cancer Receiving Chemotherapy

Start date: February 2014
Phase: N/A
Study type: Interventional

This pilot phase II trial studies how well bovine lactoferrin supplement works in improving taste in patients with cancer receiving chemotherapy. Bovine lactoferrin supplement may help improve the ability to taste food in patients who are receiving chemotherapy.

NCT ID: NCT01896778 Completed - Melanoma Clinical Trials

Body Warming in Improving Blood Flow and Oxygen Delivery to Tumors in Patients With Cancer

Start date: October 4, 2013
Phase: N/A
Study type: Interventional

This randomized pilot clinical trial studies body warming in improving blood flow and oxygen delivery to tumors in patients with cancer. Heating tumor cells to several degrees above normal body temperature may kill tumor cells.

NCT ID: NCT01884584 Completed - Malignant Neoplasm Clinical Trials

Potential Use of Indocyanine Green as a Fluorescent Agent for Definition of Surgical Margins in Cancer

Start date: June 2012
Phase: Phase 1
Study type: Interventional

The surgeon may remove a very small amount of additional tissue compared to what would be removed if you were not enrolled in the study. This tissue may prove to contain tumor or it may contain normal tissue. The surgical cavity will be examined by a special laser pen after the tumor is removed, and if areas of fluorescence are seen, that may indicate tumor cells where the ICG dye collected are still remaining and the surgeon would then remove those. After the tumor and the tissue around it are removed and sent to the laboratory, the tissue may be examined using that same laser pen to see where the cancer cells are and compare that to what the laboratory sees when it looks at the tumor and tissue with a microscope. It is hoped that what the dye shows and what is seen with the microscope will be alike.